Cannabis Bioscience International Holdings, Inc.

Overview

Compare with OneMedNet Corp, iSpecimen Inc. or Absci Corp, or pick any stock.

• TickerCBIH on OTC¹
• IndustryServices-Commercial Physical & Biological Research¹
• HeadquartersHouston, Texas¹
• Incorporated inCO³
• Business address6201 Bonhomme Road, Suite 435S, Houston, Tx 77036³
• Filer categoryNon-accelerated filer, Smaller reporting company, Emerging growth company³

See how the biggest companies compare on our leaderboards

Economics), which confirms its continuous expansion in both recreational and medical segments.⁴ From its latest annual report

What it owns

What Cannabis Bioscience International Holdings, Inc. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

Properties, in its own words

The Company leases approximately 1,367 square feet at 6201 Bonhomme Road, Suite 435N, Houston, Texas, under a lease dated April 12, 2024, and amended on June 18, 2025. The lease, as amended, added a one-year term that commenced on June 1, 2025, at a base rent of $1,730 per month. For information regarding the recording of the right-of-use asset and the lease liability in the consolidated balance sheets, see Note 5 to the Company’s financial statements.

Two of the Company’s officers leased 1,400 square feet in Houston, Texas (the “Officers’ Leased Property”), under a lease, the term of which commenced on February 29, 2020, and expired on March 14, 2022, at a rent of $3,449 per month. These officers made a portion of these premises available to the Company for office space on a month-to-month basis, for which the Company paid them $2,817 per month. On March 15, 2022, these officers entered into a new lease for the same premises, which expired on September 14, 2022, at a rent of $3,008 per month, and these officers continued to make a portion of these premises available to the Company for use as office space, for which the Company is paying them $2,817 per month on a month-to-month basis. On September 15, 2022, the officers that leased the Officers’ Leased Property entered into a new lease for these premises, which expired on March 14, 2023, at a rent of $3,038 per month, and these officers continued to make a portion of these premises available to the Company for use as office space, for which the Company paid them $2,817 per month. On March 2, 2023, these officers entered into a new lease for the same premises, which expires on September 14, 2023, at a rent of $3,168 per month and they continued to make a portion of these premises available to the Company for use as office space, for which the Company paid them $2,817 per month. On September 6, 2023, these officers entered into a new lease of this property, which commenced on September 15, 2023, and will expire on September 14, 2024, at a rent of $3,164 per month and they are made a portion of these premises available to the Company for use as office space, for which the Company is paying them $2,817 per month.

Item 2 of the 10-K filed Sep 22, 2025.⁴

Former names

• CHINA INFRASTRUCTURE CONSTRUCTION CorpSep 29, 2009 to Aug 24, 2022³
• FIDELITY AVIATION CORPSep 25, 2007 to Sep 15, 2009³

Timeline

1. Jan 22, 20258-K Entered a material agreement⁸
2. Nov 26, 20248-K Executive or director change; Other events⁹
3. Aug 22, 20248-K Entered a material agreement; Executive or director change; Bylaws or fiscal year changed¹⁰
4. Mar 28, 20248-K Entered a material agreement¹¹
5. Dec 14, 20238-K Other events¹²

Filings

60 filings to the SEC since October 2021: 2 annual reports, 11 quarterly reports, 5 major events, 42 other. The latest 20:

1. Aug 31, 2026NT 10-K FORM 10-K EXTENSION EDGAR
2. Jul 1, 2026253G2 EDGAR
3. May 21, 2026253G2 EDGAR
4. May 11, 2026144 EDGAR
5. Apr 16, 202610-Q FORM 10-Q FEB 2026 EDGAR
6. Apr 15, 2026253G2 EDGAR
7. Apr 14, 2026NT 10-Q EXTENSION EDGAR
8. Apr 13, 2026QUALIF EDGAR
9. Apr 8, 2026CORRESP EDGAR
10. Apr 1, 2026UPLOAD EDGAR
11. Mar 27, 20261-A EDGAR
12. Feb 19, 202610-Q FORM 10-Q FOR NOV 2025 EDGAR
13. Jan 14, 2026NT 10-Q EXTENSION EDGAR
14. Oct 22, 202510-Q FORM 10-Q FOR AUGUST 2025 EDGAR
15. Oct 15, 2025NT 10-Q EXTENSION EDGAR
16. Sep 22, 202510-K FORM 10-K FOR MAY 2025 EDGAR
17. Sep 2, 2025NT 10-K NOTIFICATION OF LATE FILING EDGAR
18. May 9, 202510-Q/A AMENDMENT NO 1 EDGAR
19. Apr 22, 202510-Q FORM 10-Q FOR FEB 2025 EDGAR
20. Apr 14, 2025NT 10-Q FORM 12B-25 EDGAR

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

SEC filer profile

How Cannabis Bioscience International Holdings, Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

• Name on EDGARCannabis Bioscience International Holdings, Inc.¹
• CIK0001411057
• Employer ID (EIN)84-4901299⁴
• Filer statusNon-accelerated filer an emerging growth company; a smaller reporting company; a shell company⁴
• Incorporated inColorado⁴
• Fiscal year endsMay 31¹
• Industry code (SIC)8731 Services-Commercial Physical & Biological Research¹
• SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance¹
• Business address6201 Bonhomme Road, Suite 435S, Houston, TX 77036¹
• Phone214-733-0868¹
• Shares outstanding11,626,749,347 as of Apr 16, 2026⁷
• Public float$2.9M as of Nov 29, 2024⁴
• AuditorVictor Mokuolu, CPA PLLC, Houston, Texas PCAOB ID 6771; no auditor attestation of internal control over financial reporting⁴
• On EDGAR sinceSep 25, 2007¹
• Filings142 in all: 10-Q (22), 8-K (22), CORRESP (14), NT 10-Q (14), UPLOAD (14), S-1/A (11), 10-Q/A (6), 10-K (5)¹
  All 26 form types

  NT 10-K (5), 253G2 (3), 424B3 (3), D (3), EFFECT (3), SC 13G/A (3), S-1 (2), SB-2/A (2), 1-A (1), 10KSB (1), 144 (1), 15-15D (1), 8-K/A (1), QUALIF (1), REGDEX (1), S-8 (1), SB-2 (1), SC 13G (1)

• Latest filingsAnnual report (10-K) Sep 22, 2025
  Quarterly report (10-Q) Apr 16, 2026
  Latest 8-K (8-K) Jan 22, 2025